Pharmafile Logo
Pharmafocus logo
Advanced Search

compugen

Showing 3 posts of 3 posts found.

Gilead and Compugen enter exclusive license agreement for immunotherapy programme

December 20, 2023
Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology

Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …

News
medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …

News

Bayer signs cancer vaccine research deal

August 6, 2013
Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026